Workflow
最新基金经理主观投资榜揭晓!梁宏、王文、但斌等上榜!
Sou Hu Cai Jing·2025-08-06 10:19

Core Viewpoint - The A-share market has shown a significant upward trend since the U.S. tariff impact on April 7, with the Shanghai Composite Index reaching above 3600, indicating a favorable environment for subjective investment strategies to outperform the market [1] Group 1: Performance of Subjective vs. Quantitative Funds - As of July 25, 2023, the average return for 1,231 quantitative private equity products was 4.74%, while 2,303 subjective private equity products achieved an average return of 5.74% over the same period [1] - The average return for subjective long-only products from private equity managers with assets over 5 billion reached 11.91%, with 96.30% of products showing positive returns [1][2] Group 2: Top Performing Fund Managers - The top three subjective private equity fund managers for the year include Tong Xun from Tongben Investment, Lu Hang from Fusheng Asset, and Wang Yiping from Evolutionary Asset, with their respective products achieving significant returns [1][3] - Tong Xun manages three products with a total scale of approximately 302 million yuan, while Lu Hang oversees five products totaling about 1.109 billion yuan [3] Group 3: Performance by Fund Size Categories - For funds sized 20-50 billion, the average return was 15.32%, with 91.16% of products showing positive returns, led by Xu Hongbing from Shenzhen Dream Factory Investment [5][6] - In the 10-20 billion category, the average return was 27.08%, with all products achieving positive returns, led by Sun Jie from Nengjing Investment [7][8] - The 5-10 billion category saw an average return of 22.88%, with Liu Xianglong from Fuyuan Capital leading the performance [10][11] - For the smallest category (0-5 billion), the average return was 18.36%, with Yao Yong from Qinxing Fund achieving the highest performance [13][14] Group 4: Investment Strategies and Focus Areas - Tong Xun and Lu Hang have successfully captured the "new consumption" trend, focusing on sectors that are expected to benefit from economic stabilization and differentiation [3][4] - Xu Hongbing emphasizes traditional business logic in investment, while Chen Yu from Shennong Investment focuses on innovative pharmaceuticals, which have seen significant market interest [7][9] - The investment philosophy of Yao Yong from Qinxing Fund is rooted in extensive company research, leveraging over 20 years of experience in the field [15]